Related Experiment Video
Updated: Aug 7, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Deep cervical abscesses in children: efficacy of the cefotaxime-rifampicin combination
Céline Bory1,2, Olivier Bory3, Bruno Guelfucci2
1Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, 264 rue Saint Pierre, 13385 Cedex 05, Marseille, France.
Insights
The cefotaxime-rifampicin antibiotic protocol effectively treats pediatric deep cervical abscesses, reducing surgery needs when used first. Larger abscess size is the main factor predicting surgical intervention.
Area of Science:
- Pediatric Otorhinolaryngology
- Infectious Diseases
- Pharmacology
Background:
- Medical management is preferred for pediatric deep neck abscesses, but optimal antibiotic strategies remain debated.
- Common pathogens include Staphylococcus aureus and streptococci.
- The efficacy of specific antibiotic combinations in avoiding surgery requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of the cefotaxime-rifampicin combination in preventing surgery for pediatric deep cervical abscesses.
- To identify prognostic factors influencing the success of this medical treatment.
- To compare surgical rates between the cefotaxime-rifampicin protocol and other treatments.
Main Methods:
- Retrospective analysis of 106 pediatric patients (under 18) with para- or retro-pharyngeal abscesses (2010-2020).
- Multivariate analyses, including Kaplan-Meier curves and Cox models, assessed treatment outcomes and prognostic factors.
- Comparison between cefotaxime-rifampicin as first-line treatment versus other protocols and second-line use.
Main Results:
- First-line cefotaxime-rifampicin treatment led to significantly lower surgical rates (7.5%) compared to other protocols (32.1%).
- The benefit of cefotaxime-rifampicin was not observed when used as a second-line treatment after initial treatment failure.
- Abscess size >32 mm at hospitalization was a significant predictor of increased surgery requirement (Hazard Ratio = 8.5).
Conclusions:
- The cefotaxime-rifampicin protocol is an effective first-line medical treatment for non-complicated pediatric deep cervical abscesses.
- Early medical management with this protocol can significantly reduce the need for surgical intervention.
- Initial abscess size is a critical prognostic factor for treatment success, with larger abscesses necessitating surgery more often.
Abstract:
The objective is to determine whether a medical treatment, the combination of cefotaxime and rifampicin, is effective in avoiding surgery for managing deep cervical abscesses in children and to determine prognostic factors in the efficacy of this medical treatment. This is a retrospective analysis of all patients under 18 presenting with para- or retro-pharyngeal abscess over the period 2010-2020 in two hospitals' pediatric otorhinolaryngology departments. One hundred six records were included. Multivariate analyses were performed to study the relationship between the prescription of the Cefotaxime-rifampicin protocol at the onset of the management and the use of surgery and to evaluate the prognostic factors of its efficacy. The 53 patients who received the cefotaxime-rifampicin protocol as first-line treatment (vs. 53 patients receiving a different protocol) required surgery less frequently: 7.5% versus 32.1%, validated by a Kaplan-Meier survival curve and a Cox model analysis adjusted for age and abscess size (Hazard Ratio = 0.21). This good outcome of the cefotaxime-rifampicin protocol was not demonstrated when it was instituted as a second-line treatment after the failure of a different protocol. An abscess larger than 32 mm at hospitalization was significantly associated with more frequent use of surgery in multivariate analysis adjusted for age and sex (Hazard Ratio = 8.5). Conclusions: The cefotaxime-rifampicin protocol appears to be an effective first-line treatment in managing non-complicated deep cervical abscesses in children. What is Known: • Nowadays, medical treatment is preferred for managing deep neck abscesses in children. There has yet to be a consensus on the antibiotic therapy to be proposed. • Staphylococcus aureus and streptococci are the most frequent causative organisms. What is New: • The cefotaxime-rifampicin protocol introduced at first intention is effective, with only 7.5% of patients requiring drainage surgery. • The only risk factor for failure of the medical treatment is the initial size of the abscess.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management
Tonsillitis II: Management
Urine Studies II: Urine Culture and Sensitivity Test

